This molecular cascade links ALK mutational activation to both EMT phenotype acquisition and clinically observed aggressiveness in ALK-rearranged tumors (54), indicating that this mutation promotes tumor progression and augments its metastatic potential. Here, ALK is linked to neoplasm.